rs138347314

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_001040616.3(LINS1):​c.1194A>G​(p.Gln398Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00353 in 1,608,822 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0023 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0037 ( 10 hom. )

Consequence

LINS1
NM_001040616.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.471

Publications

1 publications found
Variant links:
Genes affected
LINS1 (HGNC:30922): (lines homolog 1) The Drosophila segment polarity gene lin encodes a protein, lines, which plays important roles in development of the epidermis and hindgut. This gene encodes a protein containing a lines-like domain. This gene is located on chromosome 15 and clustered with the gene encoding ankyrin repeat and SOCS box-containing protein 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2017]
LINS1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal recessive 27
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • autosomal recessive non-syndromic intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.04).
BP6
Variant 15-100573679-T-C is Benign according to our data. Variant chr15-100573679-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 211378.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.471 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00227 (346/152336) while in subpopulation NFE AF = 0.00395 (269/68032). AF 95% confidence interval is 0.00357. There are 0 homozygotes in GnomAd4. There are 155 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 10 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LINS1NM_001040616.3 linkc.1194A>G p.Gln398Gln synonymous_variant Exon 5 of 7 ENST00000314742.13 NP_001035706.2 Q8NG48-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LINS1ENST00000314742.13 linkc.1194A>G p.Gln398Gln synonymous_variant Exon 5 of 7 5 NM_001040616.3 ENSP00000318423.8 Q8NG48-1

Frequencies

GnomAD3 genomes
AF:
0.00228
AC:
347
AN:
152218
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000893
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00190
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00397
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00211
AC:
522
AN:
247486
AF XY:
0.00228
show subpopulations
Gnomad AFR exome
AF:
0.000618
Gnomad AMR exome
AF:
0.00174
Gnomad ASJ exome
AF:
0.00132
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000790
Gnomad NFE exome
AF:
0.00364
Gnomad OTH exome
AF:
0.00233
GnomAD4 exome
AF:
0.00366
AC:
5331
AN:
1456486
Hom.:
10
Cov.:
32
AF XY:
0.00363
AC XY:
2627
AN XY:
724616
show subpopulations
African (AFR)
AF:
0.000453
AC:
15
AN:
33134
American (AMR)
AF:
0.00186
AC:
82
AN:
43988
Ashkenazi Jewish (ASJ)
AF:
0.00131
AC:
34
AN:
25980
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39672
South Asian (SAS)
AF:
0.0000234
AC:
2
AN:
85460
European-Finnish (FIN)
AF:
0.000862
AC:
46
AN:
53360
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5742
European-Non Finnish (NFE)
AF:
0.00451
AC:
5003
AN:
1108972
Other (OTH)
AF:
0.00244
AC:
147
AN:
60178
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
239
479
718
958
1197
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
200
400
600
800
1000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00227
AC:
346
AN:
152336
Hom.:
0
Cov.:
34
AF XY:
0.00208
AC XY:
155
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000890
AC:
37
AN:
41576
American (AMR)
AF:
0.00190
AC:
29
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10614
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00395
AC:
269
AN:
68032
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
18
35
53
70
88
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00301
Hom.:
0
Bravo
AF:
0.00244
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00365
EpiControl
AF:
0.00332

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

LINS1: BP4, BP7 -

not specified Benign:1
Mar 14, 2016
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jul 06, 2016
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
1.2
DANN
Benign
0.23
PhyloP100
-0.47
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138347314; hg19: chr15-101113884; COSMIC: COSV100130481; COSMIC: COSV100130481; API